Перевести на Переведено сервисом «Яндекс.Перевод»

Acura Pharmaceuticals

Country
USA
Краткое название
Acura Pharmaceuticals
Headquarters
616 N. North Court Suite 120
Members of the board

Robert B. Jones,
President & Chief Executive Officer
Peter A. Clemens,
Senior Vice President, Chief Financial Officer
James F. Emigh R.PH.,
Vice President, Corporate Development
Robert A. Seiser CPA,
Vice President, Treasurer and Corporate Controller
Albert W. Brzeczko Ph.D.,
Vice President, Technical Affairs
J. Bradley Rivet,
Vice President, Marketing
Ronald L. Leech,
Senior Director Quality & Analytical Chemistry
John G. Gilkay P.E.,
Director of EHS & Engineering
Gregory A. Spinner,
Director of Logistics and Special Projects

Categories medicine
Therapy
Stage of the project
Production
Disease
Metabolic syndrome
Ticker
ACUR
Current owners

Robert B. Jones,
President & Chief Executive Officer
George Ross,
Early Stage Business Consultant
William G. Skelly,
President and Chief Executive Officer, Central Biomedia, Inc.
Immanuel Thangaraj,
Managing Director and General Partner, Essex Woodlands Health Ventures
Bruce F. ,Toby, Wesson,
Founder, Senior Advisor; Galen Partners

Assets
49.2100
Technology
Services, Technologies, Pharmaceuticals, Chemistry